ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Citadel Advisors 2,500$2,3130.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 181,600$167,9800.00%
B. Riley Wealth Advisors, Inc. 12,060$11,1550.00%
TWO SIGMA ADVISERS, LP 96,937$89,6670.00%
Daiwa Securities Group Inc. 469$00.00%
SIMPLEX TRADING, LLC 9,408$80.00%
CAPTRUST FINANCIAL ADVISORS 21,924$20,2800.00%
Qube Research & Technologies Ltd 100,150$92,6390.00%
Carmichael Hill & Associates, Inc. 525$4860.00%
Investors Research Corp 200$1850.00%
Global Retirement Partners, LLC 6,000$5,5500.00%
Lindbrook Capital, LLC 4,610$4,2640.00%
SALEM INVESTMENT COUNSELORS INC 52$490.00%
Cutler Group LLC / CA 1,511$10.00%
Beaird Harris Wealth Management, LLC 92$860.00%
Worth Asset Management, LLC 600$5550.00%
JPMORGAN CHASE & CO 1,304,914$1,207,0450.00%
BARCLAYS PLC 50,061$460.00%
COMMONWEALTH EQUITY SERVICES, LLC 31,875$290.00%
ROYAL BANK OF CANADA 159$00.00%
External links

This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q2 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.